Capital Group Investment Management Pte. Ltd. Crispr Therapeutics Ag Transaction History
Capital Group Investment Management Pte. Ltd.
- $536 Million
- Q2 2025
A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 12,145 shares of CRSP stock, worth $878,326. This represents 0.11% of its overall portfolio holdings.
Number of Shares
12,145
Previous 14,572
16.66%
Holding current value
$878,326
Previous $495,000
19.19%
% of portfolio
0.11%
Previous 0.11%
Shares
9 transactions
Others Institutions Holding CRSP
# of Institutions
541Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$736 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$405 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$266 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$237 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$206 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.64B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....